C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway  by Perianayagam, Mary C. et al.
Kidney International, Vol. 61 (2002), pp. 456–463
C5a delays apoptosis of human neutrophils by a
phosphatidylinositol 3-kinase-signaling pathway
MARY C. PERIANAYAGAM, V.S. BALAKRISHNAN, ANDREW J. KING, BRIAN J.G. PEREIRA,
and BERTRAND L. JABER
Division of Nephrology, Department of Medicine, Tupper Research Institute, New England Medical Center, Tufts University
School of Medicine, Boston, Massachusetts, USA
C5a delays apoptosis of human neutrophils by a phosphatidyl- activation and a significant delay in apoptosis [3]. This
inositol 3-kinase-signaling pathway. regulation of neutrophil survival is influenced by a vari-
Background. Studies have shown that survival factors in- ety of inflammatory mediators, such as bacterial lipo-cluding cytokines and growth factors delay apoptosis of human
polysaccharide (LPS) [4, 5], cytokines [4–6], hematopoi-neutrophils via induction of the phosphatidylinositol-3 kinase
etic growth factors [7], complement fragments [4, 5], and(PI 3-K)/Akt pathway. In the present study, we explored
whether complement fragment C5a has a modulatory effect extracellular matrix proteins [8].
on neutrophil apoptosis through this signaling pathway. Neutrophil survival requires the active inhibition of
Methods. Human neutrophils were isolated and treated with apoptosis, which is accomplished either by inhibiting cas-
C5a for up to 24 hours, with or without wortmannin, a PI 3-K
pases or by preventing their activation. Signaling path-inhibitor, and staurosporine, a caspase-9 activator. Apoptosis
ways involving phosphatidylinositol-3 kinase (PI 3-K)was quantified by flow cytometry, using propidium iodide nu-
clear staining, and confirmed by the detection of DNA frag- have been implicated in several cellular responses includ-
mentation on gel electrophoresis. PI 3-K downstream signaling ing protection from apoptosis [9]. This pathway leads to
events were evaluated by measuring the expression of cytosolic the activation of Akt, a cytosolic serine/threonine kinase
total and phosphorylated Akt and Bad proteins by Western that acts downstream of PI 3-K [10, 11]. The function ofblot analyses, and caspase-9 activity.
Akt is largely undefined, but it acts as an effector of PIResults. C5a inhibited neutrophil apoptosis in a dose- and
3-K to prevent cells from undergoing apoptosis [10, 11].time-dependent manner. The anti-apoptotic effects of C5a
were markedly abrogated in the presence of wortmannin. Brief Cell permeable inhibitors of PI 3-K such as wortmannin
stimulation of neutrophils with C5a induced phosphorylation have proved to be critically important not only as more
of Akt and Bad proteins through a PI 3-K–dependent pathway. efficient tools to examine the Akt pathway, but also as
Caspase-9 activity was minimal in C5a-treated cells, but mark-
a fundamental evidence for the function of PI 3-K in aedly increased following PI 3-K inhibition by wortmannin. Fi-
specific receptor-mediated signaling pathway [9].nally, C5a reduced caspase-9 activity in staurosporine-treated
Activation of the complement cascade via either thecells.
Conclusions. This study demonstrates that C5a inhibits neu- classical or alternative pathway results in the generation
trophil apoptosis via a PI 3-K signaling pathway. This effect of several complement fragments, especially C5a, which
may be an important mechanism that improves cell survival is a potent immuno-modulatory molecule [12]. C5a hasand function in the inflammatory milieu.
been implicated in the pathogenesis of glomerulonephri-
tis [13] and neutrophil-mediated ischemic re-perfusion
injury [14]. It also contributes to the increased adhesive-Neutrophils are short-lived leukocytes that are com-
ness of neutrophils that takes place during hemodialysis
mitted to undergo apoptosis under normal conditions with cellulose-based membranes, which results in tran-
[1, 2]. During inflammatory responses, neutrophil trans- sient margination and pulmonary leukostasis [15, 16]. In
migration into tissues is associated with increased cellular this study, we tested the hypothesis that complement
factor C5a down-regulates neutrophil apoptosis, using
primarily the PI 3-K/Akt signaling pathway.Key words: polymorphonuclear cells, neutrophils, cell death, inflam-
mation, complement, kinase, PI 3-K, Akt, Bad, caspase-9, wortmannin,
staurosporine.
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The Human Investigation Review Committee approved Qualitative detection of apoptosis
by DNA electrophoresiscollection of blood samples and all participants gave
informed consent. DNA fragmentation was analyzed by agarose gel elec-
Neutrophils (20  106/mL) were harvested by Percoll trophoresis as previously prescribed [19]. In brief, neu-
gradient (63/69%) followed by hypotonic lysis of eryth- trophils (10  106/mL) were washed and lysed overnight
rocytes as previously described [17]. Cell purity (95%) at 37C, in extraction buffer containing 50 mmol/L Tris,
and viability (99%) were assessed by the Trypan blue 10 mmol/L ethylenediaminetetraacetic acid (EDTA),
exclusion method. Cells were re-suspended in RPMI- 1% sodium dodecyl sulfate (SDS) and 250 g/mL pro-
teinase K. DNA was precipitated with twice the volume1640 supplemented with 10 mmol/L l-glutamine, 24
of ethanol and one-tenth the volume of 3 mol/L sodiummmol/L NaHCO3, (Mallinckrodt, Paris, KY, USA), 10
acetate, and re-suspended in Tris-EDTA (10 mmol/Lmmol/L HEPES (Sigma Chemical Co., St. Louis, MO,
Tris and 1 mmol/L EDTA at pH 8.0) containing 250USA), 100 U/mL streptomycin (Irvine Scientific, Santa
g/mL of RNAse. Purified DNA was electrophoresedAna, CA, USA) and 10% fetal calf serum (FCS) for
in 1.2% agarose gel containing ethidium bromide. DNAculture conditions.
was visualized under ultraviolet illumination and photo-
graphed using Polaroid film.Cell culture
To examine the effect of C5a on neutrophil apoptosis, Western blot analyses for Akt and Bad proteins
cells were incubated at 37C in a humidified atmosphere
To examine PI 3-K downstream signaling events, thecontaining 5% CO2, with rising concentrations of com- expression of cytosolic total and phosphorylated Akt andplement component C5a (0.5 to 2 g/mL; Sigma), and
Bad proteins was measured by Western blot analyses. Inwith or without wortmannin (100 nmol/L; Sigma), a se-
brief, neutrophils (10  106 cells) were incubated with
lective inhibitor of PI 3-kinase. After 6 and 24 hours of
rising concentrations of C5a (0 to 2 g/mL) for five
incubation, cell aliquots were processed for quantifica- minutes in the presence or absence of wortmannin (100
tion of apoptosis as described below. nmol/L) at 37C. Following this brief incubation period,
cells were centrifuged at 450  g for five minutes. ToQuantitative detection of apoptosis by flow cytometry
the cell pellets, cell lysis buffer [10 mmol/L Tris-HCl at
Apoptosis was quantified by flow cytometry using pro- pH 7.6, 140 mmol/L NaCl, 1% Triton X-100, 5 mmol/L
pidium iodide (PI) nuclear staining, as previously de- EDTA and 2 mmol/L phenylmethylsulfonyl fluoride
scribed [18]. In brief, cell aliquots were centrifuged and (PMSF)] was added, and the suspension was incubated
pellets were fixed in 2 mL of ice-cold 70% ethanol for for 30 minutes at 4C. Protein concentration was deter-
a minimum of two hours. Cells were then washed in mined using the Bradford reagent (Sigma). The cell ly-
phosphate-buffered saline (PBS), re-suspended in 0.5 sates were subjected to 10% sodium dodecyl sulfate
mg/mL of RNAse (Type XII-A; Sigma), and incubated polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to a nitrocellulose filter. The membranesfor 15 minutes at room temperature. Propidium iodide
were blocked using non-specific interactions with PBS-T(50 g/mL) was then added and cell suspensions were
(PBS at pH 7.4 with 0.1% Tween 20) containing 5% block-kept on ice in the dark for 15 to 30 minutes until analyzed
ing agent for one hour. Immunoblotting was performedby flow cytometry. Flow cytometric analysis was carried
using a rabbit anti-human Akt polyclonal antibody (Cellout at a flow rate of 1000 events/second by using a dual
Signaling, Beverly, MA, USA) or a mouse anti-humanlaser flow cytometer (FACscan; Becton Dickinson, San
Phospho-Akt (within the C-terminus at Ser473) mono-Jose, CA, USA). A total of 10,000 events were counted.
clonal antibody (Cell Signaling). After a 12-hour incuba-Cell debris and clumps were excluded from the analysis
tion at 4C, the membranes were washed with PBS-Tby gating single cells in the forward and side light scat-
and respectively incubated with secondary anti-rabbit or
ters. Propidium iodide was excited using the 488-nm
anti-mouse antibodies coupled to horseradish peroxidase
ultraviolet line of the Argon laser. For each experiment, for one hour at room temperature. After three washes
neutrophils were immediately fixed after isolation, and with PBS-T, immunoreactive bands were visualized by
analyzed first, to determine the gates delineating the using enhanced chemiluminescence (ECL) Western blot-
hypodiploid cell population with low PI uptake. Neutro- ting detection reagents (Amersham, Piscataway, NJ, USA)
phils with low PI uptake were considered apoptotic. Ac- according to the manufacturer’s instructions.
quired data were analyzed with Mac-based software Similar experiments were performed to examine the
(FlowJo; Tree Star, Inc., San Carlos, CA, USA). The expression of cytosolic total and phosphorylated BAD
proportion of apoptotic neutrophils was defined as the proteins, using rabbit anti-human Bad or anti-human
number of apoptotic cells divided by the total number Phospho-Bad (at Ser136) polyclonal antibodies (Cell
Signaling).of cells  100.
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Fig. 1. Dose- and time-dependent effect of C5a on apoptosis of human neutrophils. (A) Dose-dependent effect. Cells were treated with C5a (0
to 2 g/mL) for 24 hours, and processed for quantification of apoptosis by flow cytometry. *P  0.01 vs. control conditions; **P  0.005 vs. control
conditions. Data are means  SEM of 10 experiments. (B) Time-dependent effect. Cells were control () or treated with C5a alone (2 g/mL;
) or C5a plus wortmannin (100 nmol/L; ) for 6 and 24 hours, and processed for quantification of apoptosis by flow cytometry. *P  0.02 C5a
vs. control conditions; **P  0.02 C5a  wortmannin vs. C5a conditions; †P  0.04 C5a  wortmannin vs. C5a conditions. Data are means 
SEM of 7 experiments.
Densitometric analyses of the images were performed mental results. Results are expressed as OD and fold
change in caspase-9 activity.using the Scion Image 3b acquisition and analysis soft-
ware (Scion Corp., Frederick, MD, USA). Optical den-
Statistical analysissity (OD) calibration was used for all analyses using a
generic mapping of brightness to OD. This calibration Statistical analysis was performed using the Statistical
Package for Social Sciences version 10.0 (SPSS, Chicago,was used for comparison of lane bands in the same digital
image. IL, USA). Comparisons between groups were made by
ranked non-parametric Kruskall Wallis analysis of vari-
Measurement of caspase-9 activity ance (ANOVA) or Friedman test, and two-tailed Mann
Whitney test (unpaired and paired) for continuous vari-To examine the effect of C5a on caspase-9 activity, we
used a commercially available colorimetric assay (R & D ables. Results are expressed as means  standard error
of the mean (SEM). Differences were considered statisti-Systems, Minneapolis, MN, USA). In brief, neutrophils
(2 106 cells) were incubated alone, or with wortmannin cally significant at P values of less than 0.05.
(100 nmol/L) or C5a (2 g/mL) in the presence or ab-
sence of wortmannin. In addition, cells were incubated
RESULTS
with staurosporine (0 to 20 mol/L), a known stimulator
Time- and dose-dependent effect of C5aof caspase-9 activity. The latter experiments were per-
on neutrophil apoptosisformed with or without a 30-minute pre-exposure to C5a
(2 g/mL). Following a four-hour incubation at 37C, The dose-dependent effect of C5a on neutrophil apo-
ptosis is shown in Figure 1A (N  10). Compared withcells were pelleted at 250  g for 10 minutes. The super-
natant was gently removed and discarded while the cell unstimulated conditions (64.4 2.0%), neutrophils treated
with 0.5 g/mL (43.8  3.3%), 1 g/mL (39.9  4.5%)pellet was lysed with a commercially provided lysis
buffer. The cell lysate was incubated on ice for ten min- and 2 g/mL (31.5  2.9%) of C5a had marked delay
in apoptosis (P	 0.01 vs. unstimulated conditions). Thisutes and then centrifuged at 10,000  g for one min-
ute. Caspase-9 activity was measured in a 96-well flat effect was confirmed by gel electrophoresis. Indeed, as
shown in Figure 2, compared with unstimulated condi-bottom microplate. Cell lysate reaction buffer containing
5 mol/L dithiothreitol (DTT; 50 L) and LEHD-p- tions, inter-nucleosomal DNA fragmentation was almost
undetectable at 24 hours in cells treated with rising con-nitroaniline (LEHD-pNA; 5 L), a caspase-9 colorimet-
ric substrate, were added to the microplate and incubated centrations of C5a.
Time-dependent effect of C5a on neutrophil apoptosisfor one hour at 37C. The plate was read at 405-nm
single wavelength, using a microplate reader (MRX-500; is shown in Figure 1B (N  7). Compared with unstimu-
lated conditions, neutrophils treated with C5a (2 g/mL)Dynatech Laboratories Inc., Chantilly, VA, USA). Back-
ground control values were subtracted from the experi- displayed marked delay in cellular apoptosis at 6 (8.6 
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was reduced by 43% in the presence of wortmannin (P
0.07).
Dose-dependent effect of C5a on Bad phosphorylation
Figure 4 shows a representative immunoblot and
pooled data from five experiments examining Bad phos-
phorylation of C5a-treated neutrophils in the presence or
absence of wortmannin. Western blot analyses revealed
that human neutrophils constitutively express Bad pro-
tein (data not shown). Bad phosphorylation was minimal
at time 0, but markedly increased at five minutes in
the presence of C5a (Fig. 4A), and was reduced in the
presence of wortmannin (P  0.02 by Friedman test;
Fig. 4B). Indeed, compared with unstimulated condi-
tions, 0.5, 1 and 2 g/mL of C5a resulted in a respective
Fig. 2. Gel electrophoresis of intact and fragmented DNA isolated 56% (P  0.08), 71% (P  0.04) and 147% (P  0.04)
from C5a-treated human neutrophils. Cells were treated with C5a (0 increase in Bad phosphorylation, which was reduced byto 2 g/mL) for 24 hours, and processed for quantification of apoptosis
34% in the presence of wortmannin (P  0.04).by gel electrophoresis. Lane M, 123 bp ladder.
Effect of C5a on caspase-9 activity
Figure 5 shows pooled OD data from six experiments
2.4% vs. 4.4  1.1%; P  0.018) and 24 hours (50.3  examining caspase-9 activity of untreated, wortmannin-
5.9% vs. 31.1  6.2%; P  0.018). and C5a-treated neutrophils in the presence or absence
We next explored whether the anti-apoptotic effects of wortmannin. Caspase-9 activity was undetectable at
of C5a were mediated in part by the PI 3-K-signaling time 0, and detectable at four hours in untreated and
pathway. As shown in Figure 1B, compared with unstim- C5a-treated cells. Compared with untreated cells, cas-
ulated conditions, the anti-apoptotic effects of C5a were pase-9 activity decreased by only 8% in the presence
markedly reduced in the presence of wortmannin (a spe- of C5a. However, compared with C5a-treated cells, the
cific PI 3-K inhibitor) at 6 (15.1  2.9% vs. 4.4  1.1%; addition of C5a and wortmannin together resulted in a
P  0.018) and 24 hours (44.9  4.3% vs. 31.1  6.2%; 229% increase in caspase-9 activity (P  0.03). Of note,
P  0.043). caspase-9 activity also increased by 95% in wortmannin-
treated cells compared with untreated cells.Time- and dose-dependent effect of C5a
In exploring whether caspase-9 activation by stauro-on Akt phosphorylation
sporine, a potent caspase-9 activator, could be inhibited
C5a-mediated downstream signaling events leading to by pre-exposure of cells to C5a, a dose-dependent effect
delayed apoptosis are unknown. As shown above, since of staurosporine on caspase-9 activity was observed. In-
wortmannin provided indirect evidence for the involve- deed, 5, 10 and 20 mol/L of staurosporine resulted in
ment of PI 3-K/Akt in a specific receptor-mediated sig- a 0.7 0.2-fold, 0.6 0.1-fold, and 1.7 0.8-fold increase
naling pathway, we next explored whether C5a directly in caspase-9 activity, respectively. However, compared
induces Akt phosphorylation in human neutrophils. with the 20 mol/L dose of staurosporine, pre-exposure
Time-dependent effect of C5a on Akt phosphorylation of cells to C5a resulted in a 2.7  0.5-fold decrease in
was rapid, and the peak effect was observed after three caspase-9 activity (P  0.028; N  6).
to five minutes of cell exposure to C5a (data not shown).
Figure 3 shows a representative immunoblot and
DISCUSSIONpooled data from four experiments examining Akt phos-
phorylation of C5a-treated neutrophils in the presence or Under normal conditions, cells are constantly negoti-
ating a balance of factors and signals that determineabsence of wortmannin. Western blot analyses revealed
that human neutrophils constitutively express Akt pro- whether survival or apoptosis will be the chosen course of
action. Elements controlling this balance include cellulartein (data not shown). Akt phosphorylation was minimal
at time 0, and markedly increased at five minutes in and genomic integrity, availability of growth and survival
factors, and death signals generated during immune re-the presence of C5a (Fig. 3A), which was abrogated by
wortmannin (P  0.03 by Friedman test; Fig. 3B). In- sponses. Aberrant inputs into survival/apoptosis control
figure prominently in human disease ranging from de-deed, compared with unstimulated conditions, 0.5, 1 and
2 g/mL of C5a resulted in a respective 24%, 108% and generative disorders to cancer.
In humans, little is known about the function and130% (P 0.07) increase in Akt phosphorylation, which
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Fig. 3. Dose-effect of C5a on phosphoryla-
tion of Akt protein in human neutrophils.
Cells were treated with C5a (0 to 2 g/
mL)wortmannin (100 nmol/L) for 5 minutes,
and cell lysates were immunoblotted with ei-
ther anti-Akt or anti-phosphorylated (Ser473)
Akt antibody. (A) The upper panel is a rep-
resentative immunoblot of Akt phosphory-
lation. (B) The lower panel represents the
pixel values of Akt phosphorylation that were
pooled from four separate experiments, yield-
ing similar results (P 0.03 by Friedman test).
Fig. 4. Dose-effect of C5a on phosphoryla-
tion of BAD protein in human neutrophils.
Cells were treated with C5a (0 to 2 g/
mL)  wortmannin (100 nmol/L) for five
minutes, and cell lysates were immunoblotted
with either anti-BAD or anti-phosphorylated
(Ser136) BAD antibody. (A) A representative
immunoblot of BAD phosphorylation. (B)
Pixel values of BAD phosphorylation that
were pooled from five separate experiments,
yielding similar results (P  0.02 by Friedman
test).
apoptosis [3]. Once in situ, the regulation of neutrophil
survival is critical to the propagation and resolution of
inflammation. Dysregulation of this process has been
implicated in the pathogenesis of prolonged or inappro-
priate inflammation in severe infection, autoimmune dis-
orders, and possibly atherosclerosis [20, 21]. In chronic
inflammatory diseases, persistent accumulation and acti-
vation of neutrophils is associated with tissue injury lead-
ing to organ dysfunction [22, 23]. At sites of inflamma-
tion, the fate of neutrophils is influenced by a variety of
mediators, including microbial products such as LPS,
cytokines, and hematopoietic growth factors [4–8]. These
mediators have been shown to delay neutrophil apopto-
sis by inducting the PI 3-K/Akt signaling transductionFig. 5. Effect of C5a on caspase-9 activity. Neutrophils were incubated
alone (control), with wortmannin (Wt) (100 nmol/L) or C5a (2 g/ pathway [7].
mL)  Wt. *P  0.03 vs. C5a alone. Data are means  SEM of 6 Signaling pathways involving PI 3-K protect cells fromexperiments.
undergoing apoptosis. Akt is a major hub for the input
and output of kinase signaling pathways, and plays a
critical role in survival signaling. Indeed, this proteinsurvival of neutrophils in acutely inflamed tissues. Ac-
kinase is activated downstream from PI 3-K, and oncecording to experimental data, the process of leukocyte
phosphorylated, Akt inhibits the pro-apoptotic Bcl-2 fam-transmigration into tissues is associated with increased
cellular activation and a significant delay of spontaneous ily member Bad and directly inhibits caspase-9 [10, 11].
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Indeed, Bad phosphorylation results in its dissociation
from the anti-apoptotic Bcl-2 family member BclxL, which
in turn prevents caspase-9 activation [24, 25].
In the present study, we explored whether comple-
ment fragment C5a modulates neutrophil apoptosis us-
ing a PI 3-K–dependent pathway. The results indicate
that C5a inhibits neutrophil apoptosis in a dose- and
time-dependent manner. In addition, neutrophil stimula-
tion with C5a induced rapid phosphorylation of Akt and
Bad proteins. Further, both the anti-apoptotic effects of
C5a and Akt/Bad phosphorylation were diminished in
the presence of wortmannin, a specific PI 3-K inhibitor.
Caspase-9 activity minimally decreased in C5a-treated
cells, but markedly increased when PI 3-K was inhibited
by wortmannin. Finally, C5a reduced caspase-9 activity
in staurosporine-treated cells.
C5a is a complement fragment that has multifunctional
properties [12]. It plays an important role in the patho-
genesis of complement-mediated glomerulonephritides
[13]. In addition, C5a is a potent chemo-attractant for
neutrophils. Indeed, it induces the up-regulation of adhe-
sion molecules on the cell-surface of neutrophils, which
promotes transmigration into inflammatory tissues [12,
14, 16]. The systemic effects of C5a following comple-
ment activation by bio-artificial surfaces such as during
hemodialysis also are well documented [15]. In addition,
elevated complement factor D (an essential enzyme of
the alternative pathway of complement) concentration
has been observed in renal failure, which also may have
Fig. 6. Proposed mechanisms for C5a-mediated delayed apoptosis inpathophysiological consequences on C5a generation [26].
human neutrophils. C5a binds to complement receptor (CR), whichComplement-mediated downstream signaling events activates phosphatidyl inositol 3-kinase, leading to Akt phosphoryla-
leading to delayed apoptosis are unknown. Our data tion. This in turn phosphorylates Bad protein, which may prevent mito-
chondrial leakage of cytochrome c. The caspase cascade is consequentlyindicate that the PI 3-K/Akt signaling pathway mediates
inhibited, leading to delayed cellular apoptosis (↓  activation; ⊥ the survival-promoting effect of C5a. These findings are inhibition).
in agreement with other studies, which have shown that
hematopoietic growth factors, including granulocyte-
macrophage colony-stimulating factor (GM-CSF) and
tions are still clinically relevant, as tissue levels of in-erythropoietin also can delay programmed cell death of
flammatory mediators are higher than systemic levels.neutrophils and vascular smooth muscle cells, respec-
Indeed, among patients suffering from pneumonia, C5atively, by activating the PI 3-K pathway [7, 27].
levels in broncho-alveolar lavage fluids can range be-There are several limitations in our study that are
tween 1 and 10 g/mL [32].worthy of mention. Inhibition of PI 3-K in human neutro-
We failed to observe a marked reduction in caspase-9phils had a partial effect on C5a-mediated cell survival,
activity of C5a-treated neutrophils compared with un-suggesting for the role of additional survival signaling
treated cells, whereas PI 3-K inhibition with wortmannin,pathway that are independent of PI 3-K/Akt. The p44/42
irrespective of C5a, enhanced caspase-9 activity. Previ-mitogen-activated protein kinase (MAPK), also known
ous studies have shown that Akt activation can indepen-as the extracellular signal-regulated kinase or ERK path-
dently phosphorylate pro-caspase-9, thereby inhibitingway, can be activated by growth factors/mitogens, and
its activation [33]. It is unclear whether C5a can directlyhas been linked to prolonged cellular survival [7, 28, 29].
phosphorylate pro-caspase-9 through the PI 3-K signal-It remains to be determined whether C5a employs this
ing pathway. In separate experiments, we used high-pathway to mediate neutrophil survival.
doses of staurosporine to maximally activate caspase-9The C5a concentrations used in our experiments were
and observed that pre-exposure to C5a markedly re-significantly higher than that encountered in the plasma
duced caspase-9 activity. Although this finding does notof patients undergoing hemodialysis or during sepsis
(less than 0.1g/mL) [30, 31]. However, these concentra- unravel the intrinsic mechanism by which C5a inhibits
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6. Kettritz R, Gaido ML, Haller H, et al: Interleukin-8 delaysapoptosis, it does support the hypothesis that C5a can
spontaneous and tumor necrosis factor-alpha–mediated apoptosisinhibit caspase-9 activation following potent apoptotic of human neutrophils. Kidney In 53:84–91, 1998
stimuli. 7. Klein JB, Rane MJ, Scherzer JA, et al: Granulocyte-macrophage
colony-stimulating factor delays neutrophil constitutive apoptosisFinally, studies on the signal transduction pathway
through phosphoinositide 3-kinase and extracellular signal-regu-involved in C5a-mediated neuronal protection suggest
lated kinase pathways. J Immunol 164:4286–4291, 2000
that C5a inhibits programmed cell death via receptor- 8. Kettritz R, Xu YX, Kerren T, et al: Extracellular matrix regulates
apoptosis in human neutrophils. Kidney Int 55:562–571, 1999dependent phosphorylation of the ERK2 pathway and
9. Franke TF, Kaplan DR, Cantley LC: PI3K: Downstream AKTdirect inhibition of caspase-3 activity [34]. It remains
ion blocks apoptosis. Cell 88:435–437, 1997to be determined whether this caspase-9–independent 10. Bonni A, Brunet A, West AE, et al: Cell survival promoted by
pathway is operative in human neutrophils. Such a mech- the Ras-MAPK signaling pathway by transcription-dependent and
independent mechanisms. Science 286:1358–1362, 1999anism would explain the discrepancy in our results be-
11. Datta SR, Brunet A, Greenberg ME: Cellular survival: A playtween the inability to demonstrate marked reduction in
in three Akts. Genes Dev 13:2905–2927, 1999
caspase-9 activity by C5a alone, contrasting with the 12. Goldstein IM: Complement: Biologically active products, in In-
flammation Basic Principles and Clinical Correlates, edited by Gal-ability of this molecule to inhibit staurosporine-induced
lin JI, Goldstein IM, Synderman R, New York,, Raven Press,caspase-9 activation. We speculate that C5a stimulates
1992, pp 63–80several survival signaling pathways that result in delayed 13. Johnson RJ: Involvement of complement in renal disease. Curr
apoptosis. Opin Nephrol Hypertens 6:120–127, 1997
14. Jordan JE, Zhao ZQ, Vinten-Johansen J: The role of neutrophilsIn summary, this study demonstrates that C5a inhibits
in myocardial ischemia-reperfusion injury. Cardiovasc Res 43:860–neutrophil apoptosis via a PI 3-K-dependent pathway
878, 1999
(Fig. 6). This may be a protective mechanism by which 15. Pereira BJG, Cheung AK: Biocompatibility of hemodialysis mem-
branes, in Dialysis and Transplantation: A Companion to Brennercomplement activation improves neutrophil survival and
and Rector’s The Kidney, edited by Owen WF, Pereira BJG,function in the inflammatory milieu. In a recent update
Sayegh MH, Philadelphia, W.B. Saunders Company, 1999, ppon the molecular control of neutrophil apoptosis, two 32–56
out of five studies demonstrated BclXL expression by 16. Rousseau Y, Carreno MP, Poignet JL, et al: Dissociation between
complement activation, integrin expression and neutropenia duringhuman neutrophils [35]. Additional studies will be re-
hemodialysis. Biomaterials 20:1959–1967, 1999quired to examine the effect of C5a on neutrophil-associ-
17. Metcalf JA, Gallin JI, Nauseef WM, Root RK: Laboratory
ated MAPK, mainly the ERK pathway, and to see Manual of Neutrophil Function. New York, Raven Press, 1986
18. Nicoletti I, Migliorati G, Pagliacci MC, et al: A rapid and simplewhether in human neutrophils, Bad phosphorylation
method for measuring thymocyte apoptosis by propidium iodidedoes result in its dissociation from BclXL.
staining and flow cytometry. J Immunol Methods 139:271–279, 1991
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